Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group
Cet article passe en revue les résultats importants présentés en 2021 lors du symposium de l'ASCO sur les cancers gastro-intestinaux puis analyse l'intégration de ces résultats dans une pratique clinique de routine
Last year the field of immunotherapy was finally introduced to GI oncology, with several changes in clinical practice such as advanced hepatocellular carcinoma or metastatic colorectal MSI-H. At the virtual ASCO-GI symposium 2021, several large trial results have been reported, some leading to a change of practice. Furthermore, during ASCO-GI 2021, results from early phase trials have been presented, some with potential important implications for future treatments. We provide here an overview of these important results and their integration into routine clinical practice.
British Journal of Cancer , article en libre accès, 2021